Recent Development in the Search for Epidermal Growth Factor Receptor (EGFR) Inhibitors based on the Indole...

Area of Science:

• Oncology
• Medicinal Chemistry
• Molecular Biology

Background:

• Epidermal growth factor receptor (EGFR) is a key regulator of cell signaling and proliferation, implicated in various cancers.
• Targeting EGFR is a validated strategy for treating breast, lung, cervical, glioma, and bladder cancers.
• Acquired resistance to existing EGFR inhibitors necessitates the development of novel therapeutic agents.

Purpose of the Study:

• To review indole-based compounds as potent inhibitors of the epidermal growth factor receptor.
• To explore the structure-activity relationships of these inhibitors with EGFR active sites.
• To discuss their synthesis and molecular docking for potential drug development.

Main Methods:

• Literature review focusing on indole-based EGFR inhibitors.
• Analysis of structure-activity relationships (SAR) of identified compounds.
• In silico molecular docking studies to assess binding affinity to EGFR.

Main Results:

• Indole-based scaffolds demonstrate significant potential as EGFR inhibitors.
• Specific structural modifications correlate with enhanced binding and inhibitory activity.
• Molecular docking studies predict favorable interactions with the EGFR active site.

Conclusions:

• Indole-based inhibitors represent a promising class of compounds for overcoming EGFR inhibitor resistance.
• Further research into SAR and synthesis can lead to novel anti-cancer drugs.
• Targeting EGFR with novel agents remains a critical strategy in cancer therapy.